Legal Representation
Attorney
Allison L. Ko
USPTO Deadlines
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 30, 2025 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jul 29, 2025 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Jan 28, 2025 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jan 28, 2025 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jan 28, 2025 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Dec 21, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 20, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 20, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 20, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 20, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 20, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 1, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 1, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 1, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 21, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 14, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 6, 2024 | WOAG | I | WITHDRAWAL OF ATTORNEY GRANTED | Loading... |
| Aug 6, 2024 | WOAR | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | Loading... |
| Apr 8, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Intravaginal drug delivery systems including compounds that facilitate delivery of pharmaceuticals; combination drug products, namely, pharmaceutical preparations incorporated within intervaginal rings configured for vaginal insertion to enable delivery of pharmaceutical preparations from the intravaginal ring
Class 042
Pharmaceutical drug development services; pharmaceutical drug delivery research services; research and development of new products in the nature of combination drug delivery; development of combination drug products for intravaginal delivery
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"HEALTH"